News coverage contributes to drug shortages in COVID-19

NewsGuard 100/100 Score

Researchers at Boston Children's Hospital in the U.S. have reported that the recent shortage of medicines used to treat coronavirus disease 2019 (COVID-19) could be due to extensive news media coverage that results in individual hoarding or institutional stockpiling of medicines. The study is currently available on the medRxiv* preprint server.

Study: News Coverage and Drug Shortages during the COVID-19 Pandemic. Image Credit: tommaso79 / Shutterstock
Study: News Coverage and Drug Shortages during the COVID-19 Pandemic. Image Credit: tommaso79 / Shutterstock

*Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

As of October 16, 2020, highly infectious and deadly severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 38.8 million people and claimed more than 1 million lives globally. Rigorous testing, together with strict implementation of non-pharmaceutical control measures (masking, hand washing/sanitizing, movement restriction, etc.), is believed to be the most effective way to contain the viral spread.

Regarding pharmaceutical interventions to manage COVID-19 patients, several medicines have been proposed for repurposing as COVID-19 treatment. However, the US Food and Drug Administration (FDA) has reported that there is a nation-wide shortage of many of these medicines.

In the current study, the scientists investigated if this shortage is caused by the hoarding of drugs by individuals or stockpiling of drugs by institutions. They also investigated whether media news coverage has any influence on drug hoarding/stockpiling.

Current study design

The scientists analyzed US news media coverage and internet search related to eight repurposed medicines reported to be in shortage by the FDA between January 1, 2020, and June 30, 2020. These medicines include azithromycin, famotidine, hydroxychloroquine, cisatracurium, dexmedetomidine, continuous renal replacement therapy (CRRT), midazolam, and propofol.

A pharmacist associated with federal COVID-19 response selected and categorized eight repurposed medicines based on the data collected from the American Society of Hospital Pharmacists and national and international workgroups.

Of eight medicines, three were categorized as “able to be hoarded by individuals or stockpiled by institutions,” as people can directly purchase these medicines from pharmacies. These medicines include azithromycin, famotidine, and hydroxychloroquine.   

Five repurposed medicines, including cisatracurium, dexmedetomidine, continuous renal replacement therapy (CRRT), midazolam, and propofol, were categorized as “able to be stockpiled by institutions only,” as people generally do not purchase these medicines on their own.

For each medicine, the scientists analyzed news media coverage by Media Cloud’s National Corpus. They separately analyzed the media coverage about medicines, excluding the word “shortage” and medicines, including the word “shortage.” Regarding internet search volume for each repurposed medicine, the scientists collected the data from Google Health Trends.

Important observations

For all three medicines that can be individually hoarded or institutionally stockpiled, news about medicines either including or excluding the word “shortage” sharply increased before the FDA-announced shortage. Moreover, internet searches related to these medicines also increased significantly before the shortage announcement.

A similar trend was observed for five medicines that are most likely to be stockpiled by institutions only. Media news about these medicines, either including or excluding the word “shortage,” also sharply increased before the FDA-announced shortage. However, no variation in internet search related to these medicines was observed before the shortage announcement.

Study significance

The study findings indicate that extensive news media coverage about essential COVID-19 treatment medicines can influence the hoarding/stockpiling behaviors of both individuals and institutions prior to the shortage. This, in turn, can deprive COVID-19 patients who are in the actual need of these medicines for off-label usage.

The increase in internet search patterns observed in the study indicates that people who are influenced by news actually try to look for medicines they can directly purchase and hoard for future use.

Because institutions are less likely to search drug-related information on the internet before purchasing, no variation in internet search pattern was observed in the case of medicines that can only be purchased by institutions. Thus, internet search trends seem to differentiate between individual hoarding and institutional stockpiling correctly.  

*Important notice: medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Journal reference:
Dr. Sanchari Sinha Dutta

Written by

Dr. Sanchari Sinha Dutta

Dr. Sanchari Sinha Dutta is a science communicator who believes in spreading the power of science in every corner of the world. She has a Bachelor of Science (B.Sc.) degree and a Master's of Science (M.Sc.) in biology and human physiology. Following her Master's degree, Sanchari went on to study a Ph.D. in human physiology. She has authored more than 10 original research articles, all of which have been published in world renowned international journals.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Dutta, Sanchari Sinha Dutta. (2020, October 15). News coverage contributes to drug shortages in COVID-19. News-Medical. Retrieved on April 25, 2024 from https://www.news-medical.net/news/20201015/News-coverage-contributes-to-drug-shortages-in-COVID-19.aspx.

  • MLA

    Dutta, Sanchari Sinha Dutta. "News coverage contributes to drug shortages in COVID-19". News-Medical. 25 April 2024. <https://www.news-medical.net/news/20201015/News-coverage-contributes-to-drug-shortages-in-COVID-19.aspx>.

  • Chicago

    Dutta, Sanchari Sinha Dutta. "News coverage contributes to drug shortages in COVID-19". News-Medical. https://www.news-medical.net/news/20201015/News-coverage-contributes-to-drug-shortages-in-COVID-19.aspx. (accessed April 25, 2024).

  • Harvard

    Dutta, Sanchari Sinha Dutta. 2020. News coverage contributes to drug shortages in COVID-19. News-Medical, viewed 25 April 2024, https://www.news-medical.net/news/20201015/News-coverage-contributes-to-drug-shortages-in-COVID-19.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Association of estrogen-containing menopause hormonal therapy with COVID-19 mortality